Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

UBS Sticks to Bullish Outlook for JNJ with Fresh Price Target

Guavy AI Editorial Team
Instruments
JNJ
Share

UBS analyst Michael Yee has reaffirmed his positive stance on Johnson & Johnson (NYSE: JNJ) by reiterating a Buy rating and setting a price target of $320.00.

The analyst's commentary, dated September 22, 2026, highlights the company's strong fundamentals and potential for continued growth.

With this latest update, investors may be looking to take advantage of the analyst's optimistic view on JNJ's future performance.

More on Stocks

Stocks 6m ago

Korea Seeks Homegrown AI Model to Tackle Unique Cyber Threats

Stocks 7m ago

Cisco Teams Up with Notre Dame to Build an AI-Ready Network

Stocks 7m ago

Cisco and KETS Achieve Quantum Security Breakthrough with Integrated QKD Technology

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy